Group One Trading’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$19.7K 8330
2025
Q2
$19.7K Buy
+200
New +$18.9K ﹤0.01% 6268
2025
Q1
Sell
-5,100
Closed -$463K 7524
2024
Q4
$463K Buy
5,100
+4,800
+1,600% +$441K ﹤0.01% 3231
2024
Q3
$29K Hold
300
﹤0.01% 5015
2024
Q2
$27.5K Hold
300
﹤0.01% 4983
2024
Q1
$27.6K Sell
300
-2,500
-89% -$234K ﹤0.01% 5178
2023
Q4
$266K Buy
2,800
+1,900
+211% +$177K ﹤0.01% 3601
2023
Q3
$84.1K Buy
900
+200
+29% +$18.5K ﹤0.01% 4614
2023
Q2
$64K Sell
700
-600
-46% -$49.2K ﹤0.01% 5048
2023
Q1
$95.6K Sell
1,300
-14,300
-92% -$1.24M ﹤0.01% 4338
2022
Q4
$1.3M Buy
15,600
+15,500
+15,500% +$1.4M ﹤0.01% 2190
2022
Q3
$10K Sell
100
-2,700
-96% -$322K ﹤0.01% 6474
2022
Q2
$294K Sell
2,800
-7,400
-73% -$945K ﹤0.01% 3924
2022
Q1
$1.76M Buy
10,200
+10,000
+5,000% +$1.49M ﹤0.01% 2529
2021
Q4
$32K Sell
200
-1,100
-85% -$177K ﹤0.01% 6663
2021
Q3
$194K Buy
+1,300
New +$270K ﹤0.01% 5206
2021
Q2
Sell
-11,500
Closed -$3.04M 8097
2021
Q1
$3.04M Buy
11,500
+8,100
+238% +$2.28M ﹤0.01% 2020
2020
Q4
$997K Sell
3,400
-400
-11% -$103K ﹤0.01% 2644
2020
Q3
$898K Buy
+3,800
New +$864K ﹤0.01% 2299
2020
Q2
Sell
-1,300
Closed -$239K 5745
2020
Q1
$239K Sell
1,300
-12,600
-91% -$2.24M ﹤0.01% 2613
2019
Q4
$2.32M Sell
13,900
-29,800
-68% -$4.43M 0.02% 1179
2019
Q3
$5.72M Buy
43,700
+30,500
+231% +$3.97M 0.05% 509
2019
Q2
$1.6M Buy
13,200
+11,600
+725% +$1.38M 0.01% 1249
2019
Q1
$197K Buy
+1,600
New +$201K ﹤0.01% 2717
2018
Q3
Sell
-14,000
Closed -$1.2M 5145
2018
Q2
$1.2M Buy
+14,000
New +$1.03M 0.01% 1542
2017
Q4
Sell
-5,000
Closed -$280K 4799
2017
Q3
$280K Buy
+5,000
New +$264K ﹤0.01% 2519
2013
Q3
Sell
-16,400
Closed -$191K 5144
2013
Q2
$191K Buy
+16,400
New +$188K ﹤0.01% 2214

Other funds holding AMED

Group One Trading's AMED Position: Q3 2025 in Review

Group One Trading sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,555 shares — an estimated $350K sold.

Group One Trading first reported a position in AMED in Q3 2013 and held it in 22 quarters. The position peaked at $1.9M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Group One Trading reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 3,555 Amedisys shares in Q3 2025, an estimated $350K.
  • Group One Trading first reported a position in Amedisys in Q3 2013 and held it in 22 quarters.
  • Group One Trading's Amedisys position peaked at $1.9M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.